Be a PRO & get up to 50% off on select brands. Explore Now

business

R&D spends weighed heavily on Q4 margins: Ajanta Pharma

The pharma company had posted strong fourth quarter profits but margins had contracted. The R&D spend for the quarter stood at 9 percent, says Yogesh M Agrawal, Managing Director of the company.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections